Have a personal or library account? Click to login
Comparison of salivary interleukin-6, interleukin-8, C - reactive protein levels and total antioxidants capacity of obese individuals with normal-weight ones Cover

Comparison of salivary interleukin-6, interleukin-8, C - reactive protein levels and total antioxidants capacity of obese individuals with normal-weight ones

Open Access
|Nov 2022

References

  1. 1. ABARCA-GÓMEZ L., ABDEEN ZA., HAMID ZA., ABU-RMEILEH NM., ACOSTACAZARES B., ACUIN C., et al.Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. The lancet. 2017;390(10113):2627–42.10.1016/S0140-6736(17)32129-3573521929029897
  2. 2. WHO. global database on body mass index. 2006.
  3. 3. TILG H., MOSCHEN AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology. 2006;6(10):772–83.10.1038/nri193716998510
  4. 4. SJÖHOLM Å., NYSTRÖM T. Inflammation and the etiology of type 2 diabetes. Diabetes/metabolism research and reviews. 2006;22(1):4–10.10.1002/dmrr.56815991254
  5. 5. WEISBERG SP., MCCANN D., DESAI M., ROSENBAUM M., LEIBEL RL., FERRANTE AW. Obesity is associated with macrophage accumulation in adipose tissue. The Journal of clinical investigation. 2003;112(12):1796–808.10.1172/JCI200319246
  6. 6. DESAI GS., MATHEWS ST. Saliva as a non-invasive diagnostic tool for inflammation and insulin-resistance. World journal of diabetes. 2014;5(6):730.10.4239/wjd.v5.i6.730426585925512775
  7. 7. GOODSON JM., KANTARCI A., HARTMAN M-L., DENIS GV., STEPHENS D., HASTURK H., et al. metabolic disease risk in children by salivary biomarker analysis. PloS one. 2014;9(6):e98799.10.1371/journal.pone.0098799405160924915044
  8. 8. NIBALI L., FEDELE S., D’AIUTO F., DONOS N. Interleukin-6 in oral diseases: a review. Oral diseases. 2012;18(3):236–43.10.1111/j.1601-0825.2011.01867.x22050374
  9. 9. DAIGO K., INFORZATO A., BARAJON I., GARLANDA C., BOTTAZZI B., MERI S., et al.Pentraxins in the activation and regulation of innate immunity. Immunological reviews. 2016;274(1):202–17.10.1111/imr.12476541295427782337
  10. 10. CHRISTODOULIDES N., MOHANTY S., MILLER CS., LANGUB MC., FLORIANO PN., DHARSHAN P, et al.Application of microchip assay system for the measurement of C-reactive protein in human saliva. Lab on a Chip. 2005;5(3):261–9.10.1039/b414194f15726202
  11. 11. ABDULJABBAR T., AL-SAHALY F., KELLESARIAN SV., KELLESARIAN TV., AL-ANAZI M., AL-KHATHAMI M., et al.Comparison of peri-implant clinical and radiographic inflammatory parameters and whole salivary destructive inflammatory cytokine profile among obese and non-obese men. Cytokine. 2016;88:51–6.10.1016/j.cyto.2016.08.01727560655
  12. 12. KIM C., PARK H., KAWADA T., KIM JH., LIM D., HUBBARD N., et al.Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. International journal of obesity. 2006;30(9):1347–55.10.1038/sj.ijo.080325916534530
  13. 13. TAM CS., GARNETT SP., COWELL CT., HEILBRONN LK., LEE JW., WONG M., et al.IL-6, IL-8 and IL-10 levels in healthy weight and overweight children. Hormone research in paediatrics. 2010;73(2):128–34.10.1159/00027763220190550
  14. 14. HERNÁNDEZ-TREJO M., MONTOYA-ESTRADA A., TORRES-RAMOS Y., ESPEJELNÚÑEZ A., GUZMÁN-GRENFELL A., MORALES-HERNÁNDEZ R., et al.Oxidative stress biomarkers and their relationship with cytokine concentrations in overweight/obese pregnant women and their neonates. BMC immunology. 2017;18(1):1–11.10.1186/s12865-016-0184-6521978428061809
  15. 15. PUNJ A., SHENOY S., KUMARI NS., PAMPANI P. Estimation of antioxidant levels in saliva and serum of chronic periodontitis patients with and without ischemic heart disease. International journal of dentistry. 2017;2017.10.1155/2017/1965697552508128781595
  16. 16. GREABU M., BATTINO M., MOHORA M., TOTAN A., SPINU T., TOTAN C., et al.Could constitute saliva the first line of defence against oxidative stress? Romanian journal of internal medicine= Revue roumaine de medecine interne. 2007;45(2):209–13.
  17. 17. BELLAGAMBI FG., LOMONACO T., SALVO P., VIVALDI F., HANGOUËT M., GHIMENTI S., et al.Saliva sampling: Methods and devices. An overview. TrAC Trends in Analytical Chemistry. 2020;124:115781.
  18. 18. Obesity and Overweight. [Internet]. 2021.
  19. 19. ZYŚK B., OSTROWSKA L., SMARKUSZ-ZARZECKA J. Salivary Adipokine and Cytokine Levels as Potential Markers for the Development of Obesity and Metabolic Disorders. International Journal of Molecular Sciences. 2021;22(21):11703.10.3390/ijms222111703858404734769133
  20. 20. DELGADO I., HUET L., DEXPERT S., BEAU C., FORESTIER D., LEDAGUENEL P., et al.Depressive symptoms in obesity: relative contribution of low-grade inflammation and metabolic health. Psychoneuroendocrinology. 2018;91:55–61.10.1016/j.psyneuen.2018.02.03029525586
  21. 21. HOTAMISLIGIL GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177–85.10.1038/nature2136328179656
  22. 22. WILLIAMSON S., MUNRO C., PICKLER R., GRAP MJ., ELSWICK R. Comparison of biomarkers in blood and saliva in healthy adults. Nursing research and practice. 2012;2012.10.1155/2012/246178335084622619709
  23. 23. HAN MS., WHITE A., PERRY RJ., CAMPOREZ J-P., HIDALGO J., SHULMAN GI., et al.Regulation of adipose tissue inflammation by interleukin 6. Proceedings of the National Academy of Sciences. 2020;117(6):2751–60.10.1073/pnas.1920004117702215131980524
  24. 24. ZHANG N., LV H., SHI B-H., HOU X., XU X. Inhibition of IL-6 and IL-8 production in LPS-stimulated human gingival fibroblasts by glycyrrhizin via activating LXRα. Microbial pathogenesis. 2017;110:135–9.10.1016/j.micpath.2017.06.02128652177
  25. 25. KHAODHIAR L., LING PR., BLACKBURN GL., BISTRIAN BR. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. Journal of Parenteral and Enteral Nutrition. 2004;28(6):410–5.10.1177/014860710402800641015568287
  26. 26. PÎRSEAN C., NEGUȚ C., STEFAN-VAN STADEN R-I., DINU-PIRVU CE., ARMEAN P., UDEANU DI. The salivary levels of leptin and interleukin-6 as potential inflammatory markers in children obesity. PLoS One. 2019;14(1):e0210288.10.1371/journal.pone.0210288631781630605486
  27. 27. DOĞAN GE., TORAMAN A., ŞEBIN SÖ., DOĞAN Ç., GÜNGÖR A., AKSOY H., et al.Salivary IL-6 and IL-10 levels in subjects with obesity and gingivitis. Am J Dent. 2016;29(5):261–5.
  28. 28. LO GIUDICE G., NICITA F., MILITI A., BERTINO R., MATARESE M., CURRÒ M., et al.Correlation of s-IgA and IL-6 salivary with caries disease and oral hygiene parameters in children. Dentistry journal. 2019;8(1):3.10.3390/dj8010003717529231892186
  29. 29. ISOLA G., GIUDICE AL., POLIZZI A., ALIBRANDI A., MURABITO P., INDELICATO F. Identification of the different salivary Interleukin-6 profiles in patients with periodontitis: a cross-sectional study. Archives of Oral Biology. 2021;122:104997.10.1016/j.archoralbio.2020.10499733291049
  30. 30. AL-HAMOUDI N., ABDULJABBAR T., MIRZA S., AL-SOWYGH ZH., VOHRA F., JAVED F., et al.Non-surgical periodontal therapy reduces salivary adipocytokines in chronic periodontitis patients with and without obesity. Journal of investigative and clinical dentistry. 2018;9(2):e12314.10.1111/jicd.1231429322684
  31. 31. HARADA A., SEKIDO N., AKAHOSHI T., WADA T., MUKAIDA N., MATSUSHIMA K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. Journal of leukocyte biology. 1994;56(5):559–64.10.1002/jlb.56.5.559
  32. 32. OKADA H., MURAKAMI S. Cytokine expression in periodontal health and disease. Critical Reviews in Oral Biology & Medicine. 1998;9(3):248–66.10.1177/104544119800900301019715365
  33. 33. OSTROWSKA L., GORNOWICZ A., PIETRASZEWSKA B., BIELAWSKI K., BIELAWSKA A. Which salivary components can differentiate metabolic obesity? PLoS One. 2020;15(6):e0235358.10.1371/journal.pone.0235358732395532598403
  34. 34. BRESLIN WL., JOHNSTON CA., STROHACKER K., CARPENTER KC., DAVIDSON TR., MORENO JP., et al.Obese Mexican American children have elevated MCP-1, TNF-α, monocyte concentration, and dyslipidemia. Pediatrics. 2012;129(5):e1180–e6.10.1542/peds.2011-247722473371
  35. 35. KLIMIUK A., ZALEWSKA A., SAWICKI R., KNAPP M., MACIEJCZYK M. Salivary oxidative stress increases with the progression of chronic heart failure. Journal of Clinical Medicine. 2020;9(3):769.10.3390/jcm9030769714137032178375
  36. 36. MACIEJCZYK M., TARANTA-JANUSZ K., WASILEWSKA A., KOSSAKOWSKA A., ZALEWSKA A. A case-control study of salivary redox homeostasis in hypertensive children. Can salivary uric acid be a marker of hypertension? Journal of clinical medicine. 2020;9(3):837.10.3390/jcm9030837714128032204502
  37. 37. MACIEJCZYK M ZA, GERRETH, K.. Salivary Redox Biomarkers in Selected Neurodegenerative Diseases. J Clin Med. 2020;9:497.10.3390/jcm9020497707409232059422
  38. 38. CHOROMAŃSKA B., MYŚLIWIEC P., ŁUBA M., WOJSKOWICZ P., MYŚLIWIEC H., CHOROMAŃSKA K., et al.Impact of weight loss on the total antioxidant/oxidant potential in patients with morbid obesity—a longitudinal study. Antioxidants. 2020;9(5):376.10.3390/antiox9050376727868732369921
  39. 39. GUNJALLI G., KUMAR KN., JAIN SK., REDDY SK., SHAVI GR., AJAGANNANAVAR SL. Total salivary anti-oxidant levels, dental development and oral health status in childhood obesity. Journal of international oral health: JIOH. 2014;6(4):63.
  40. 40. ZALEWSKA A., KOSSAKOWSKA A., TARANTA-JANUSZ K., ZIĘBA S., FEJFER K., SALAMONOWICZ M., et al.Dysfunction of salivary glands, disturbances in salivary antioxidants and increased oxidative damage in saliva of overweight and obese adolescents. Journal of Clinical Medicine. 2020;9(2):548.10.3390/jcm9020548707409932079369
  41. 41. PELUSO I., RAGUZZINI A. Salivary and urinary total antioxidant capacity as biomarkers of oxidative stress in humans. Pathology research international. 2016.10.1155/2016/5480267476139526966611
  42. 42. BLACK S KI, SAMOLS D. C-reactive Protein. JBiol Chem. 2004;279(47):48487–90.10.1074/jbc.R40002520015337754
  43. 43. MOUTACHAKKIR M., BARAOU A., BOUKHIRA A., CHELLAK S, editors. Immunoanalytical characteristics of C-reactive protein and high sensitivity C-reactive protein. Annales de biologie clinique; 2017.10.1684/abc.2017.123228377336
  44. 44. PATHAK A., AGRAWAL A. Evolution of C-reactive protein. Frontiers in immunology. 2019;10:943.10.3389/fimmu.2019.00943650305031114584
  45. 45. YAO Z., ZHANG Y., WU H. Regulation of C-reactive protein conformation in inflammation. Inflammation Research. 2019;68(10):815–23.10.1007/s00011-019-01269-131312858
  46. 46. DONOVAN LE., JANOWITZ E., KIM JY. Escalating Risk of Metabolic Syndrome Imparted by Salivary Biomarker in Obese Children. Journal of Health, Sports, and Kinesiology. 2021;2(1):24–6.10.47544/johsk.2021.2.1.24
  47. 47. FAAM B., ZARKESH M., DANESHPOUR MS., AZIZI F., HEDAYATI M. Association between abdominal obesity and hs-CRP, IL-6 and HCY in Tehranian adults: TLGS. Iranian Journal of Diabetes and Metabolism. 2014;13(2):163–71.
DOI: https://doi.org/10.2478/rjim-2022-0013 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 215 - 221
Submitted on: May 6, 2022
Published on: Nov 23, 2022
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Deniz Safabakhsh, Mina Jazaeri, Hamidreza Abdolsamadi, Ebrahim Abassi, Maryam Farhadian, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.